eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Substudy of the IBCSG 24-02/ SOFT trial to investigate estrogen suppression for patients participating in Arms B and C of the IBCSG 24-02/ SOFT trial

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Resource Description
    This study is being done to see if shutting down the ovaries plus giving tamoxifen is better at preventing the return of breast cancer than just tamoxifen alone in premenopausal women. It will also test whether a newer hormone drug called exemustane plus suppression of the ovaries is better than tamoxifen plus suppression of the ovaries. In addition the side effects of these different treatments will be studied.
  3. Contact
    Berenberg, Jeffrey
  4. PI
    Berenberg, Jeffrey
  5. Topic
    breast disease
  6. Study Population
    Premenopausal women with resected breast cancer with ER- and/or PR-positive tumors. They must have estradiol levels in the premenopausal range after receiving chemotherapy and no metastatic disease.
  7. Website(s)
  8. Funded by
    Cancer Trials Support Unit
  9. Phase
    Phase 3 clinical trial
  10. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
  1. workflow state
  2. contributor
  3. created
  4. creator
    awendicke (Annemarie Wendicke)
  5. modified
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016